105 related articles for article (PubMed ID: 30343889)
1. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.
Shao H; Ma L; Jin F; Zhou Y; Tao M; Teng Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):243-250. PubMed ID: 30343889
[TBL] [Abstract][Full Text] [Related]
2. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract][Full Text] [Related]
3. A motif in LILRB2 critical for Angptl2 binding and activation.
Deng M; Lu Z; Zheng J; Wan X; Chen X; Hirayasu K; Sun H; Lam Y; Chen L; Wang Q; Song C; Huang N; Gao GF; Jiang Y; Arase H; Zhang CC
Blood; 2014 Aug; 124(6):924-35. PubMed ID: 24899623
[TBL] [Abstract][Full Text] [Related]
4. Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulation.
Venet F; Schilling J; Cazalis MA; Demaret J; Poujol F; Girardot T; Rouget C; Pachot A; Lepape A; Friggeri A; Rimmelé T; Monneret G; Textoris J
Hum Immunol; 2017; 78(5-6):441-450. PubMed ID: 28341250
[TBL] [Abstract][Full Text] [Related]
5. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
[TBL] [Abstract][Full Text] [Related]
6. Activation of LILRB2 signal pathway in temporal lobe epilepsy patients and in a pilocarpine induced epilepsy model.
Yue J; Li W; Liang C; Chen B; Chen X; Wang L; Zang Z; Yu S; Liu S; Li S; Yang H
Exp Neurol; 2016 Nov; 285(Pt A):51-60. PubMed ID: 27637803
[TBL] [Abstract][Full Text] [Related]
7. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
8. Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.
Alaoui L; Palomino G; Zurawski S; Zurawski G; Coindre S; Dereuddre-Bosquet N; Lecuroux C; Goujard C; Vaslin B; Bourgeois C; Roques P; Le Grand R; Lambotte O; Favier B
Cell Mol Life Sci; 2018 May; 75(10):1871-1887. PubMed ID: 29134249
[TBL] [Abstract][Full Text] [Related]
9. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors.
Umiker B; Hashambhoy-Ramsay Y; Smith J; Rahman T; Mueller A; Davidson R; Meyer C; Patankar G; Alam MM; Jaffe S; Krukenberg K; Goodman A; Spaulding V; Priess M; Dhaneshwar A; Wong M; Diiorio A; O'Malley K; McGrath L; Willer M; Pepper L; Gostissa M; Kis-Toth K; Wiederschain D; Cohen H; Shaffer DR
Mol Cancer Ther; 2023 Apr; 22(4):471-484. PubMed ID: 36780212
[TBL] [Abstract][Full Text] [Related]
11. LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis.
Li DP; Huang L; Kan RR; Meng XY; Wang SY; Zou HJ; Guo YM; Luo PQ; Pan LM; Xiang YX; Mao BB; Xie YY; Wang ZH; Yang M; He R; Yang Y; Liu ZL; Xie JH; Ma DL; Zhang BP; Shao SY; Chen X; Xu SM; He WT; Li WJ; Chen Y; Yu XF
Nat Commun; 2023 Jul; 14(1):4436. PubMed ID: 37481670
[TBL] [Abstract][Full Text] [Related]
12. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
[TBL] [Abstract][Full Text] [Related]
13. Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2.
Yang J; Shen G; Cao J; Zhang J; Gu Y; Zhang X; Jiang X; Luo M; Lu Z
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):42-47. PubMed ID: 35675737
[TBL] [Abstract][Full Text] [Related]
14. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
15. LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation.
Jiang Z; Huang Q; Chang Y; Qiu Y; Cheng H; Yang M; Ruan S; Ji S; Sun J; Wang Z; Xu S; Liang R; Dai X; Wu K; Li B; Li D; Zhao H
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38656573
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.
Zheng J; Umikawa M; Cui C; Li J; Chen X; Zhang C; Huynh H; Kang X; Silvany R; Wan X; Ye J; Cantó AP; Chen SH; Wang HY; Ward ES; Zhang CC
Nature; 2012 May; 485(7400):656-60. PubMed ID: 22660330
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer.
Matsushima H; Mori T; Ito F; Yamamoto T; Akiyama M; Kokabu T; Yoriki K; Umemura S; Akashi K; Kitawaki J
Oncotarget; 2016 Jun; 7(23):34131-48. PubMed ID: 27153547
[TBL] [Abstract][Full Text] [Related]
19. Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer.
Tsuji K; Utsunomiya H; Miki Y; Hanihara M; Fue M; Takagi K; Nishimoto M; Suzuki F; Yaegashi N; Suzuki T; Ito K
Int J Gynecol Cancer; 2017 May; 27(4):643-650. PubMed ID: 28375930
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK-NF-κB signaling pathway.
Che Q; Liu BY; Wang FY; He YY; Lu W; Liao Y; Gu W; Wan XP
Biochem Biophys Res Commun; 2014 Mar; 446(1):167-72. PubMed ID: 24582558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
